UBS raised the firm’s price target on Intuitive Surgical (ISRG) to $600 from $585 and keeps a Neutral rating on the shares. Strong procedure volume growth and system placements are likely to help sustain the stock’s momentum, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG: